Abstract
Introduction
The differential expression of chemokine receptors on T cells has been associated with their tissue migration and functional polarization [1] [2] [3] [4] [5] . For example, CXCR5 on follicular helper T cells (T FH ) mediates their homing to B cell follicles, where they provide cognate help to support antigen-driven B cell clonal expansion and somatic hypermutation [6] . Follicular B cells in turn promote the maintenance of T FH cells via ICOS-ICOS ligand interaction [7, 8] , highlighting the importance of the reciprocal cross talk between T and B cells. CXCL13 has been shown to be the major chemoattractant that directs follicular homing of B cells and T FH cells that express its specific receptor CXCR5 [9, 10] . Under homeostatic conditions, CXCL13 is preferentially enriched within B cell follicles of secondary lymphoid organs in mouse and human [11] , mainly produced by follicular stromal cells including follicular dendritic cells [12] . CXCR5-expressing CD8 + T cells have also been reported to reside in B cell follicles of human tonsils and likely migrate in response to CXCL13 [13] . Recently, CXCR5 + CD8 + follicular cytotoxic T cells (T FC ) have been shown to express high levels of TCF1 and play a major role in controlling chronic LCMV viral infections in animal models [14] [15] [16] [17] . However, the coexpression of TCF1 and CXCR5 was not evident in tumorinfiltrating T lymphocytes in mouse fibrosarcoma tumor and human melanoma samples [17] , suggesting that CXCR5 expression in CD8 + T cells may be differentially regulated in different disease settings. In addition, the frequency of CXCR5 + CD8 + T cells in peripheral blood was inversely associated with viral load in HIV patients [16] . The immunophenotypic features and transcriptional signatures of the mouse CXCR5 + CD8 + T cells were similar to T FH cells, early effector memory precursors, and "exhausted" T cells [14] [15] [16] . CXCR5 + CD8 + T cells have also been
shown to be essential for the maintenance of self-tolerance via their regulatory function on T FH activities [18] . Whether CXCR5 + CD8 + T cells play a role in human cancer is unclear.
In this study, we investigated the role of CXCR5 + CD8 + T cells in human follicular lymphoma, the most common indolent non-Hodgkin lymphoma derived from germinal center (GC) B cells. Follicular lymphoma is characterized by aberrant accumulation of malignant GC B cells, mainly caused by overexpression of B cell leukemia/lymphoma 2 (BCL-2) along with other genetic abnormalities [19] . The tumor microenvironment of follicular lymphoma consists of a variety of nonmalignant immune cells, including different T cell subsets (T FH , regulatory T cells, CD8 + T cells), macrophages, and follicular dendritic cells, all of which likely impact its pathogenesis and natural history [19] [20] [21] .
Here, we found that CXCR5 + CD8 + T cells are more abundant in follicular lymphoma tumors compared with control tonsil samples. CXCR5 + CD8 + T cells exhibited high cytotoxic activity, as evidenced by increased expression of IFN-γ, TNF-α, and granzymes, and displayed antitumor efficacy in vitro against human follicular lymphoma cells and in an experimental model of lymphoma. Moreover, they suppressed T FH function. Consistent with this, the gene signature of CXCR5 + CD8 + T cells was positively associated with overall survival in follicular lymphoma patients. Together, our results suggest that CXCR5 + CD8 + T cells play an important role in the control of human follicular lymphoma.
Materials and methods

Human blood and tissue samples
Buffy coats were obtained from normal donors at local Blood Bank and PBMCs were isolated by density gradient separation. Tonsil samples were obtained from children undergoing elective tonsillectomy. Lymph node biopsies were obtained from patients with follicular lymphoma at the time of their initial diagnosis prior to therapy. Tonsil samples and lymph node biopsies were processed into single cell suspension and used fresh or cryopreserved viably for later use. All samples were obtained after informed consent through an institutional review board-approved protocol.
Mice and tumor model
Our goal is to be able to detect the difference between experimental groups with a power of 0.8-0.9. Our previous experiments and experience have shown various variations between different knockout mice and experimental models (average SD = 20-30%). For each of the described experiments, we require sufficient animal numbers for a two-sample, equal variance t-test to detect a one standard deviation (SD) mean difference with 80% power and 5% one-sided alpha. Therefore, to satisfy these conditions, we will use 5-6 mice (6-12 weeks old) per each assay, repeated independently at least three times, to provide sufficient data for statistical analyses. OVA tumor-bearing mice were randomized into three groups. The investigators were not blinded to the group allocation. The purified T cells were labeled with carboxyfluorescein succinimidyl ester (CFSE) and then infused intravenously into EG7-OVA tumor-bearing mice (5-10 × 10 5 T cells per subset per mouse). After mice were killed, spleen, lymph nodes, and tumor tissues were extracted. Spleen and lymph nodes were mechanically disrupted into single cell suspension. Tumor tissues were cut into small pieces and then digested with Proteinase K at 37°C for 1 h. All single cell suspensions were enriched by Ficoll-Paque (Sigma-Aldrich). Single cells from tissues were labeled and analyzed by FACS. Tumor sizes were measured every 2 days. The Institutional Animal Care and Use Committee of the
University of Texas MD Anderson Cancer
Center approved all animal studies.
Flow cytometry antibodies and staining
The Dead Cell Removal Kit (Miltenyi Biotech) was used to remove dead cells from single cell suspensions of tissue samples prior to flow cytometry analysis. The following human antibodies (clones) were used: PerCP/Cy5.5-anti-CCR7 (G043H7) was from BioLegend; AF-700-anti-CD3
and PE-anti-TNF-α (MAB11) were from BD Biosciences; 
Quantitative RT-PCR
Cells were lysed using RealTime ready Cell Lysis Kit (Roche), followed by direct reverse transcription using Transcriptor Universal cDNA Master kit (Roche). Quantitative PCR (qPCR) was performed using SYBR ® Green JumpStart™ Taq ReadyMix™ (Sigma-Aldrich) on a StepOne plus instrument (Applied Biosystems) using genespecific primers (Table 1 ). The expression of individual genes was normalized to GAPDH using the ΔΔC t method.
Fluorescence microscopy imaging and analysis
Sections of frozen tonsil tissues were fixed in acetone and blocked with a super Blocker buffer (Life Technologies). After washing with PBS containing 0.1% Triton X-100, sections were incubated at 4°C overnight with rat anti-CXCR5-biotin (clone RF8B2; BD Pharmingen) and rabbit anti-CD8 polyclonal antibody (Cat no.: ab4055; Abcam). Streptavidin-Alexa 647 and goat anti-rabbit-Alexa 488 (Invitrogen) were used as secondary antibodies followed by counterstaining with DAPI (Invitrogen). Images were acquired using a Leica TSC SP8 laser scanning confocal microscope. Image deconvolution was performed with ImageJ (National Institutes of Health)
Induction of CXCR5 + T cells in vitro
Single cell suspensions from human tonsils were stained with antibody cocktails as described above. CD45RA Eomes anti-sense 5′-TGGGATTGAGTCCGTTTATG-3′
Tbx21 sense 5′-GTGACCCAGATGATTGTGCT-3′
Tbx21 anti-sense 5′-ATATGCGTGTTGGAAGCGT-3′
Prdm1 sense 5′-TACCTGGTACACACGGGAGA-3′
Prdm1 anti-sense 5′-GAGATTGCTGGTGCTGCTAA-3′
Bcl6 sense 5′-ACCCACAGTGACAAACCCTAC-3′
Bcl6 anti-sense 5′-GGTTTCTCACCGGTATGGAC-3′
Id2 sense 5′-CAACACGGATATCAGCATCC-3′
Id2 anti-sense 5′-CACACAGTGCTTTGCTGTCA-3′
Id3 sense 5′-CGCGTCATCGACTACATTCT-3′
Id3 anti-sense 5′-GATGACAAGTTCCGGAGTGA-3′
Runx1 sense 5′-CCGCAGCCATGAAGAACCAG-3′
Runx1 anti-sense 5′-TCTGCCGATGTCTTCGAGGT-3′
Runx2 sense 5′-CAGTAGATGGACCTCGGGAA-3′
Runx2 anti-sense 5′-CCTAAATCACTGAGGCGGTC-3′
Lef1 sense 5′-ACAGATCACCCCACCTCTTG-3′
Lef1 anti-sense 5′-TGAGGCTTCACGTGCATTAG-3′
Tcf7 sense 5′-TCTGCTCATGCATTACCCAC-3′
Tcf7 anti-sense 5′-AGAGAGAGAGTTGGGGGACA-3′
Gzmh sense 5′-TCTCAGGCTACCTAGCAGCA-3′
) T cells were sorted by flow cytometry. Sorted T cells were incubated overnight with plate-bound anti-CD3 (1 μg/mL, OKT3) and soluble anti-CD28 (1 μg/mL, CD28.2, eBioscience) antibodies in medium supplemented with 10% human AB sera (Valley Biomedical Inc., VA, USA) and human recombinant cytokines, TGF-β (5 ng/mL, Tonbo Biosciences) and IL-23 (25 ng/mL, Tonbo Biosciences) were added for additional 2-3 days. Phenotype of the T cells was determined by flow cytometry at the end of the culture period.
Plasmablast differentiation assay
T and B cell coculture was performed as previously described [2] . Briefly, sorted naïve (IgD RNA sequencing and data analysis 
Association analysis of follicular lymphoma cohort
The publicly available gene expression profiling data set for follicular lymphoma [21] was downloaded from the website (http://llmpp.nih.gov/follicularlymphoma). The average expression level of upregulated and downregulated CXCR5 + CD8 + T cell signature genes were computed, respectively.
The optimal cutoff value was determined by the Youden's index calculated by SPSS Statistics 21. Accordingly, patients were dichotomized into two groups at 25 percentile: low-expression group (<25 percentile) and high-expression group (≥25 percentile). Please note that only 27 out of 33 identified upregulated CXCR5 + CD8 + signature genes were retrieved from the patients' data sets. Correlation between gene expression level and patients' overall survival was analyzed with Kaplan-Meier method in SPSS. Gene expression profiling data used in this study has been submitted to GEO.
Statistical analyses
Statistical analyses to determine significant differences between paired groups were performed using two-tailed student's t tests or nonparametric two-sided Mann-Whitney U-tests as appropriate. Error bars represent standard deviation. One-way ANOVA was used to calculate univariate data set with more than two groups. Wilcoxon matchedpairs rank test was used to calculate paired samples between
two groups. Levels of significance are expressed as p-values (ns, not significant; *P < .05; **P < .01; ***P < .001; ****P < .0001). These tests were performed in the Prism 6 GraphPad Software. Accession numbers. RNA-Seq data have been deposited in GEO under accession number GSE105095.
Results
Frequency and localization of CXCR5
Flow cytometric analysis of single cell suspensions of human follicular lymphoma tumors and tonsils revealed that the proportion of CXCR5 + T cells among CD8 + T cells was ∼1.5-fold higher in follicular lymphoma specimens compared with those in tonsils (40.96 ± 18.11% versus 23.51 ± 16.01%, p < 0.01) (Fig. 1a) . Due to the differences in age between tonsil tissues (mostly from children) and follicular lymphoma (median age = 60), we cannot exclude the possibility that these differences are age dependent. In contrast, CXCR5 + CD8 + T cells were barely detectable in peripheral blood mononuclear cells (PBMCs) from both follicular lymphoma patients and healthy donors (Fig. 1a) , results consistent with previous reports in mice [13] [14] [15] [16] . CXCR5 is required for lymphocytes to enter B cell follicles, and the density of CXCR5 expression may determine the migration depth and/or residency of the lymphocytes (Fig. 1b) . Interestingly, confocal imaging analysis revealed colocalization of CXCR5 and CD8 markers in the mantle zone (MZ), but not in B cell follicles in tonsil tissues (Fig. 1c) . Similar findings were reported for mice with chronic viral infections, in which CXCR5 + CD8 + T cells were observed in the outer layer of B cell follicles in lymph nodes and spleens; however, those studies lacked precise subzone analysis [14] [15] [16] . Of note, most CXCR5 + CD8 + T cells are CD45RA − and CCR7 − in follicular lymphoma and tonsil samples (Fig. 1b, d ), indicating an effector/memory phenotype similar to those observed in CXCR5 + T FH [22, 23] and previous studies [13] . Collectively, these results suggest that CXCR5 expression on a subset of CD8 T cells is associated with their migration ability.
Phenotypic characterization and transcriptional profiling of CXCR5 + CD8 + T cells Fig. 2a upper panel) . These cells also expressed higher levels of markers associated with memory T cell development, such as CD27, CD28, and CD103, but reduced amount of CD127. These data collectively suggested that CXCR5 + CD8 + T cells might represent a subset of effector cells that have acquired certain memory T cell characteristics. These results are consistent with transcriptional profiling and phenotypic analysis of murine CXCR5 + CD8 + T cells, which suggested that these cells are closely related to early effector memory or memory precursor cells [13, 14] . This phenotypic profile, however, was not observed in similarly examined follicular lymphoma specimens, presumably because of altered microenvironmental triggers in follicular lymphoma tumors (Fig. 2a lower  panel) .
Identification of a gene signature of CXCR5 Fig. 1b-d) .
When the cutoff value is set as 4-fold change, 77 (33 upregulated and 44 downregulated) genes were selected among the 788 genes as signature genes for CXCR5 + CD8 + T cells ( Supplementary Fig. 1b and Fig. 2b) Fig. 1e ). The striking differences between CXCR5 − and CXCR5 + subsets are that the latter are more enriched in genes involved in cell mobility and viability, synapse formation, cytoskeleton transport, and cytotoxic capacity than CXCR5 − cells (Supplementary Fig. 1e ).
Interestingly, we also observed higher expression levels of Jun, Fos, JunB, and FosB in CXCR5 + cells compared with CXCR5 − cells (Fig. 2b) . These transcription factor subunits dimerize to form activating protein 1 (AP-1), which is an upstream transcription factor that regulates differentiation and functions of effector cells including induction of cytokines and cytotoxic molecules [27] [28] [29] . We also found that the two CD8 + T cells subsets showed differences in the expression of effector molecules such as granzymes and perforin, cytokine receptors, TLRs, and members of the tumor necrosis factor (TNF) superfamily and frizzled family (Fig. 2c) . High levels of AP transcription factor subunits (Jun, Fos, JunB, and FosB) and effector proteins also likely imply that CXCR5 + CD8 + cells play an active role against infection and tumor [30] .
cells are transcriptionally distinct
Analysis of the RNA-Seq data for transcription factors associated with development and function of CD8 + T cells showed that CXCR5 + CD8 + T cells expressed higher levels of EOMES and ID3, but lower levels of TBX21 (T-bet), BCL6, ID2, LEF1, RUNX1, and RUNX2 compared with CXCR5 − CD8 + T cells (Fig. 3a) . The differential expression of EOMES, TBX21, LEF1, ID2, and RUNX2 was confirmed by quantitative PCR analysis (Fig. 3b) and probes used are listed in Table 1 . The E-protein and ID protein regulatory axis is important for memory T cell generation
and CXCR5 expression in both CD4
+ and CD8 + T cells [16, 31] . We found that CXCR5 + CD8 + and CXCR5 − CD8 + T cells express similar levels of ID3, E2A (encoded by Tcf3), and HEB (encoded by Tcf12), but ID2 amounts are significantly lower in the former population (Fig. 3a) , consistent with findings in murine models [16] . Wnt signaling molecules LEF-1 (encoded by Lef1) and TCF-1 (encoded by Tcf7), and RUNX proteins have been known to regulate T cell fate [32] [33] [34] [35] . We found that LEF-1 is differentially expressed in the three T cell subsets, with CD45RA + being the highest, CXCR5 − being intermediate,
and CXCR5
+ being the lowest (Fig. 3a, b) . Unlike previously reported results in mouse studies [14, 15] , Tcf7 transcripts are similarly expressed at lower level in human CXCR5 + and CXCR5 − T cells, in comparison with CD45RA + population (Fig. 3a) . RUNX proteins (1) (2) (3) are expressed at lower levels in CXCR5 + than those in CXCR5 − counterpart (Fig. 3a) and it was recently reported that Runx3-mediated Tcf7 repression coordinately enforced acquisition of cytotoxic functions and protected the cytotoxic lineage integrity by preventing T FH -lineage differentiation [36] . It is unclear, however, whether the RUNX proteins are involved directly in regulating CXCR5 + CD8 + T cell generation. infection [16] . ID2 transcription is induced by cytokines IL-2, IL-12, or IL-21 in T cells, and repressed by TGF-β in epithelial cells [31, 37] . Furthermore, the addition of TGF-β and IL-23 to human naïve CD4 + T cells, following priming (Fig. 3c) . We also observed elevated CXCR5 expression in sorted naïve CD4 + T cell subset (in the same conditions), which is consistent with previous studies (Supplementary Fig. 3b ) [38] . The induced CXCR5 + CD8 + T cells are functional, as evidenced by their secretion of IFN-γ and TNF-α upon stimulation with PMA/ Ionomycin (Fig. 3d) . Furthermore, we found that ID2 expression was significantly lower in primary and induced CXCR5 + CD8 + T cells compared with CXCR5 − CD8 + T cells (Fig. 3e) , indicating downregulation of ID2 may be essential for the upregulation of CXCR5 expression. (Fig. 3f) . Transwell assays showed that CXCR5 + CD8 + T cells inhibited T FH function in a cell-cell contact independent manner (Fig. 3f) . However, it is unknown which soluble factors mediate this function. These results provide novel insights into the cross talk among T FH , CXCR5 + CD8 + T cells, and malignant B cells, and highlight a potential regulatory network in normal lymphoid tissues and in the pathogenesis of follicular lymphoma.
Inhibition of T FH cells by CXCR5
Cytotoxic function of CXCR5
Upon stimulation with PMA and ionomycin, both tonsillar and follicular lymphoma CXCR5 + CD8 + T cells produced markedly more effector molecules such as granzymes, perforin, IFN-γ, and TNF-α compared with CD45RA + CD8 + and/or CXCR5 − CD8 + T cells (Fig. 4a, b) . In particular, tonsillar CXCR5 + CD8 + T cells expressed high levels of granzymes A/K/M/H, but low levels of perforin and granzyme B, compared with CXCR5 − CD8 + T cells (Fig. 4a, b) . The increased abundance of effector proteins in CXCR5 + CD8 + T cells correlates well with the elevated expression of EOMES and decreased T-bet ( Supplementary  Fig. 2a-c ) [40] [41] [42] [43] . Of note, CXCR5 + compartment in follicular lymphoma showed similar expression of granzymes A/B/K and perforin as CXCR5 − CD8 + T cells, which is significantly lower than those in tonsillar CD8 + T cells (Fig. 4a, b) . These results indicate that unlike tonsillar CXCR5 + CD8 + T cells, follicular lymphoma CXCR5 + CD8 + T cells may have impaired cytotoxic capability. The functional distinction between marker-defined cell populations isolated from tonsil versus follicular lymphoma has been reported previously, which demonstrated that T FH cells isolated from follicular lymphoma produce distinct effector molecules than normal follicular T FH cells, although, they both support B cell survival and activation [20] .
Antitumor function of CXCR5
cells in vivo
Studies of mice have demonstrated that CXCR5 + CD8
+ T cells constitute a memory reservoir for effector cells in the control of viral replications during chronic viral infection and the mechanisms may involve increased secretion of effector proteins [14] and/or limiting the abundance of virally infected T FH and B cells [15] . To directly test the tumor-killing ability of CXCR5 + CD8 + T cells, we purified follicular lymphoma-infiltrating CD45RA + CXCR5 − T cells and expanded them ex vivo with TGF-β and IL-23 (as described in Fig. 3c and Supplementary Fig. 3a, b) . In a coculture assay with autologous primary follicular lymphoma tumor cells, we observed that CXCR5 + CD8 + T cells expressed increased CD107a, a functional marker for CD8 T cell degranulation [44] , and mediated increased tumor killing as compared with CXCR5 − CD8 + T cells (Fig. 4c, d and Supplementary Fig. 3a ).
To assess CXCR5 + CD8 + T cell function in vivo, we employed a syngeneic mouse EG7-OVA T cell lymphoma model. Briefly, ovalbumin-primed OT-I -specific CXCR5 + and CXCR5 − CD8 + T cells were sorted by flow cytometry and adoptively transferred into EG7-OVA tumor-bearing TCR −/− mice. We confirmed that immunization with ovalbumin CFA stimulated the generation of CXCR5 + and Supplementary Fig. 3c ). Seven days following adoptive transfer, we observed dramatically increased accumulation of CXCR5 + CD8 + T cells with higher proliferative index at the tumor site compared with naïve or CXCR5 − CD8 + T cell subsets ( Fig. 4e and Supplementary Fig. 3d upper panel) . Of note, the three T cell subsets showed similar proliferation capability in tumordraining lymph nodes ( Supplementary Fig. 3d lower panel) . Collectively, our data indicate that highly proliferative CXCR5 + CD8 + T cells may have increased ability to migrate into the tumor sites. In agreement with our ex vivo findings with human T cells (Fig. 4c, d ), adoptively transferred CXCR5 + CD8 + T cells expressed higher levels of IFN-γ, and granzymes A and B, compared with naïve or CXCR5 − counterparts (Fig. 4f) . As a consequence, CXCR5 + CD8 + T cells showed significantly enhanced antitumor effects than CXCR5 − CD8 + T cells, as evidenced by delayed tumor growth and improved survival (Fig. 4g) . Consistent with previous reports, we found that adoptively transferred CXCR5 + T cells could lose their surface CXCR5 expression following in vivo proliferation, indicating CXCR5 expression is dynamic during T cell activation and differentiation (Fig. 4e, f and Supplementary  Fig. 3d ) [14, 16] . Collectively, our data suggest that CXCR5 + CD8 + T cells have augmented tumor-control capability, which may result from both efficient migration to tumor site and enhanced cytotoxic function. Fig. 3e ). We found that patients in the high-expression group had significantly better overall survival compared to those in the low expression group (Fig. 4h) 
CD8
+ T cells (e), their expression of IFN-γ, IL-2, granzyme A and B (f) in tumor (TILs) and tumor-draining lymph nodes were analyzed. Tumor sizes (left) and survival (right) were monitored (g). Summary data from two independent experiments are shown. h Kaplan-Meier curves for overall survival in patients with follicular lymphoma with low (<25 percentile) or high expression (≥25 percentile) of upregulated CXCR5
+ CD8 + T cell signature genes are shown. P value was calculated using log-rank test 
